Renal Granulomatosis Post Intravesical Bacillus Calmette-Guerin Therapy for Non-muscle-invasive Bladder Cancer.

Abstract

Intravesical Bacillus Calmette-Guerin (BCG) immunotherapy is a proven, effective treatment for intermediate- and high-risk non-muscle-invasive bladder cancer. Minor side effects are common and expected but systemic effects can occur in <5% of treated patients. We present a rare case of a 49-year-old male that presented with fever and chills after 3 weeks of intravesical BCG therapy post transurethral resection of bladder tumor. New renal lesions were present on contrast-enhanced computed tomography scan which was histologically proven to be necrotizing renal granulomatosis.

• Authors: Karen Tran-Harding, Rashmi T Nair, Halemane Ganesh
• Journal: Journal of clinical imaging science (J Clin Imaging Sci) Vol. 8 Pg. 18 ( 2018) ISSN: 2156-7514 [Print] United States
• PMID: 29770266 (Publication Type: Case Reports)